Worldwide, pediatric uveitis (PU) are rare diseases involving 3/100.000 children and are the second cause of blindness. PU can be isolated or associated with overt or hidden systemic diseases including juvenile idiopathic arthritis, other inflammatory or auto-immune diseases, and infectious diseases. Pediatric specificities of uveitis include a more complex diagnostic and therapeutic approach. Finally, important disparities exist regarding the epidemiology, the management and the prognosis of PU between countries with low/middle-income countries and high-income ones.
The current challenges regarding PU are related to:
- A better understanding of their pathophysiology;
- Ways to reduce diagnosis delays;
- The optimal diagnosis work-up;
- The benefit-risk balance of therapeutic options;
- The long-term outcome in adulthood.
This Research Topic will welcome contributions related to any of these challenges.
Worldwide, pediatric uveitis (PU) are rare diseases involving 3/100.000 children and are the second cause of blindness. PU can be isolated or associated with overt or hidden systemic diseases including juvenile idiopathic arthritis, other inflammatory or auto-immune diseases, and infectious diseases. Pediatric specificities of uveitis include a more complex diagnostic and therapeutic approach. Finally, important disparities exist regarding the epidemiology, the management and the prognosis of PU between countries with low/middle-income countries and high-income ones.
The current challenges regarding PU are related to:
- A better understanding of their pathophysiology;
- Ways to reduce diagnosis delays;
- The optimal diagnosis work-up;
- The benefit-risk balance of therapeutic options;
- The long-term outcome in adulthood.
This Research Topic will welcome contributions related to any of these challenges.